Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT05177250
Brief Summary:
The aim of this study is to evaluate the association between BPA , paraben levels and type 2 DM patients
Detailed Description:
The first phase of the study will include a questionnaire :
* The cases and control will be asked about demographic information such as residence, age, education, and occupation.
* History of discovery of diabetes.
* Exposure to products and materials such as polycarbonate plastics, cosmetics and beverages containing bisphenol A and paraben and it will be evaluated through exposure sheet through asking about dietary exposure, Environmental exposure and medical exposure.
Then clinical evaluation including:
* Full clinical examination will be performed for cases and control.
* Anthropological data:
their weights, heights and waist circumference will be measured. The body mass index (BMI) will be calculated by weight (kg)/height (m)2 formula.
* Investigations: routine and specific investigation as blood glucose level, HbA1c and lipid profile.
* Urine specimens will be collected in clean, glass containers will labeled with the subject identification number. Turbid sample or those containing blood will be excluded.
* All specimens will be stored frozen below 20 degree centigrade.
* Urine samples will be analyzed by High Performance liquid chromatograph (HPLC) to detect bispenol A and parabens levels.
Study:
NCT05177250
Study Brief:
Protocol Section:
NCT05177250